Knowledge Distillery

Adults in receipt of a single dose of ChAdOx1 or BNT162b2 were enrolled at 12 UK sites and randomly assigned to receive concomitant administration of…

Adaptive immunity to SARS-CoV-2 and COVID-19

In this review recently published in JAMA, the authors summarise the current evidence regarding the pathophysiology, transmission, diagnosis, and…

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

In this trial, done at 43 centres in France, the authors randomly assigned patients receiving invasive mechanical ventilation for up to 72 h with…

MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells

In this multicentre retrospective observational study, the authors analysed the impact of the COVID-19 pandemic on hospital stroke admissions and…

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a…

In this article the authors aimed to use the data repositories of Israel's largest health-care organisation to evaluate the effectiveness of a third…

Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19

In this paper recently published in the official journal of the Hungarian Society of Neurologists, the authors discuss neurological signs and symptoms…

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial